🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

February 22 and 23, 2024 What is it? It is the appointment you don’t wanna miss if you’re interested in 💪🏻 challenging CHIPs 💥 calcium modification 📸 intracoronary imaging Come join us in Lucerne if you want 🔥 debates 🔝discussions 🆒 workshops luks.ch/veranstaltunge…

Coronary computed tomographic angiography (CCTA), often combined with FFRCT, is emerging as the primary tool for diagnosing coronary artery disease, assessing hemodynamic impact, and guiding revascularization planning. It effectively rules out atherosclerosis, monitors plaque

Why Does a Cardiologist Believe in a Therapy? The Role of Intuitiveness and Understanding the Mechanism ahajournals.org/doi/10.1161/CI…

The 7 best TED Talks I've ever seen: 🔖10/10 would Bookmark:

In-vivo virtual noncalcium with #photoncounting #yesCCT -> Improved stenosis grading on noncalcium images Fantastic collaboration with ccm.mc shorturl.at/int07 Mergen Victor Matthias Eberhard Robert Manka Alessandro Candreva MD Rengarajan R🇮🇳 Cardiology USZ Radiologie USZ

Must-read review on the epidemiology and burden of heart failure in Asia in the latest issue of JACC: Asia. Highlights: • In Asia, comprehensive data regarding the epidemiology and burden of HF remain limited. • This review summarizes the occurrence, causes, outcomes, and

Great study from Matthias Eberhard Mergen Victor Alessandro Candreva MD PhD Rengarajan R🇮🇳 Robert Manka and others from Radiologie USZ and Cardiology USZ JACC Journals ⬇️⬇️⬇️⬇️⬇️⬇️

Congratulations to Barbara Stähli from the Cardiology USZ and CTEC - Zurich University Heart Center on winning the Georg Friedrich Götz Prize 🏆 for outstanding internationally recognized achievement! #MULTISTARS Unispital_USZ University of Zurich #FrankRuschitzka Francesco Paneni Sara Ersözlü, MD Omer Dzemali Paneni Lab

Measurement & interpretation of hemodynamic data are integral aspects of treating patients w/ #HeartFailure. Read the key points from a state-of-the-art review on practical guidance for hemodynamic assessment by RHC in the management of HF. 🔗 bit.ly/4cHMr0S #JACCHF

Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B. This represent a paradigm shift in the diagnosis and treatment of these patients.

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC #ESCardio

In MATTERHORN, among patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral-valve surgery with respect to a composite of death, rehospitalization for heart failure, stroke, reintervention, or implantation of an

New #JACCAsia state-of-the-art comprehensive review on updated clinical data of intravascular imaging–guided #PCI and #IVUS/OCT-derived stent optimization criteria in Asia. bit.ly/3MxQz8I #ACCIntl

Please 🙏🏻 repost @OSTOLab Paul Evans Paneni Lab Simon Kraler Bettina Heidecker Alessandro Candreva MD PhD Alexander Bartelt Massimiliano Ruscica European Atherosclerosis Society EAPCPresident Victor Aboyans Borge G Nordestgaard NNF Center for Basic Metabolic Research (CBMR)

Have we come a long way in treating acute myocardial infarction? Perusing the recommendations of the 1978 Harrison's Principles of Internal Medicine will leave you appalled! futurelearn.com/courses/artifi… FutureLearn

"Is there a doctor on the plane?"✈️🩺 Responding to in-flight medical emergencies. #MedTwitter

New nature A mechanism for why durable weight loss is so difficult: epigenetic memory of fat cells nature.com/articles/s4158… Ferdinand von Meyenn Laura Hinte

Top 🔟 Clinical Trials of 2024: 🔥 PREVENT 🔥 DanGer Shock 🔥 REDUCE-AMI 🔥 CLEAR SYNERGY (OASIS 9) 🔥 And more! Read the details of the clinical trials here: bit.ly/41Kb7nn

New insights from #PROSPECTII substudy of non-culprit lesions post #cvAMI found that both physiologically sig & even non-physiologically sig lesions demonstrated a moderate-to-high presence of high-risk plaque jacc.org/doi/10.1016/j.… Gregg W. Stone MD Ketina Arslani #JACCIMG #cvImaging